21.12
-0.14(-0.66%)
Currency In HKD
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
40557
First IPO Date
October 30, 2012
| Name | Title | Pay | Year Born |
| Ms. Jing Li | Co-President and Chief Executive Officer of Established Medicines Manufacturing & Supply Division | 0 | 1972 |
| Mr. Wenjie Zhang | Co-President & Co-Chief Executive Officer of Innovative Medicines Division | 0 | 1967 |
| Dr. Yi Liu | President, Chief Executive Officer and Chairman, CEO of Fosun MedTech Div.& CEO of the Diagnostic Tech. Div. | 0 | 1975 |
| Mr. Wang Xingli M.D., Ph.D. | Co-President, Co-Chairman and Co-Chief Executive Officer of Innovative Drug Div., CEO of Global R&D Center | 0 | 1962 |
| Ms. Yue Zhu | Vice President & GM of Legal Department | 0 | 1977 |
| Ms. Rongli Feng | Executive President & Chief Human Resources Officer | 0 | 1975 |
| Mr. Zhanyu Chen | Senior Vice President & Chief Financial Officer | 0 | N/A |
| Ms. Xiaohui Guan | Executive Co-Chairman | 0 | 1971 |
| Mr. Kexin Wang | Executive Director | 0 | 1964 |
| Mr. Yuqing Chen | Executive Chairman | 0 | 1975 |
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments. The company offers pharmaceutical products in the areas of tumor, immune modulation, metabolism, alimentary and central nervous system. It also provides medical devices and diagnostic products. In addition, the company offers health care and hospital management services. Further, it engages in retail and wholesale distribution of medicines. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.
